• Dosage of Vesix Special in details
• Vesix Special interactions
• Vesix Special reviews

Dosage of Vesix Special in details

Vesix Special Dosage

Generic name: Vesix Special 20mg

Dosage form: tablet

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

Edema

Therapy should be individualized according to patient response to gain maximal therapeutic response and to determine the minimal dose needed to maintain that response.

Adults -- The usual initial dose of Vesix Special is 20 to 80 mg given as a single dose. Ordinarily a prompt diuresis ensues. If needed, the same dose can be administered 6 to 8 hours later or the dose may be increased. The dose may be raised by 20 or 40 mg and given not sooner than 6 to 8 hours after the previous dose until the desired diuretic effect has been obtained. The individually determined single dose should then be given once or twice daily (eg, at 8 am and 2 pm). The dose of Vesix Special may be carefully titrated up to 600 mg/day in patients with clinically severe edematous states.

Edema may be most efficiently and safely mobilized by giving Vesix Special on 2 to 4 consecutive days each week.

When doses exceeding 80 mg/day are given for prolonged periods, careful clinical observation and laboratory monitoring are particularly advisable.

Geriatric patients -- In general, dose selection for the elderly patient should be cautious, usually starting at the low end of the dosing range.

Pediatric patients -- The usual initial dose of oral Vesix Special in pediatric patients is 2 mg/kg body weight, given as a single dose. If the diuretic response is not satisfactory after the initial dose, dosage may be increased by 1 or 2 mg/kg no sooner than 6 to 8 hours after the previous dose. Doses greater than 6 mg/kg body weight are not recommended. For maintenance therapy in pediatric patients, the dose should be adjusted to the minimum effective level.

Hypertension

Therapy should be individualized according to the patient’s response to gain maximal therapeutic response and to determine the minimal dose needed to maintain the therapeutic response.

Adults -- The usual initial dose of Vesix Special for hypertension is 80 mg, usually divided into 40 mg twice a day. Dosage should then be adjusted according to response. If response is not satisfactory, add other antihypertensive agents.

Changes in blood pressure must be carefully monitored when Vesix Special is used with other antihypertensive drugs, especially during initial therapy. To prevent excessive drop in blood pressure, the dosage of other agents should be reduced by at least 50% when Vesix Special is added to the regimen. As the blood pressure falls under the potentiating effect of Vesix Special, a further reduction in dosage or even discontinuation of other antihypertensive drugs may be necessary.

Geriatric patients -- In general, dose selection and dose adjustment for the elderly patient should be cautious, usually starting at the low end of the dosing range.

More about Vesix Special (Vesix Special)

• Side Effects
• During Pregnancy or Breastfeeding
• Dosage Information
• Drug Images
• Drug Interactions
• Support Group
• Pricing & Coupons
• En Espanol
• 27 Reviews - Add your own review/rating
• Generic Availability

Consumer resources

• Vesix Special
• Vesix Special (Advanced Reading)
• Vesix Special Injection (Advanced Reading)

Professional resources

• Vesix Special (AHFS Monograph)
• Vesix Special (FDA)

Related treatment guides

• Edema
• Ascites
• High Blood Pressure
• Heart Failure
• Hypercalcemia
• More (5) »

What other drugs will affect Vesix Special?

Taking this medicine with alcohol or with other drugs that make you sleepy can worsen this effect. Ask your doctor before taking Vesix Special with a sleeping pill, narcotic pain medicine, muscle relaxer, or medicine for anxiety, depression, or seizures.

Vesix Special can harm your kidneys. This effect is increased when you also use certain other medicines, including: antivirals, chemotherapy, injected antibiotics, medicine for bowel disorders, medicine to prevent organ transplant rejection, injectable osteoporosis medication, and some pain or arthritis medicines (including aspirin, Tylenol, Advil, and Aleve).

Tell your doctor about all your current medicines and any you start or stop using, especially:

• chloral hydrate;

• digoxin, digitalis;

• lithium;

• phenytoin; or

• heart or blood pressure medicine.

This list is not complete. Other drugs may interact with Vesix Special, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

Vesix Special interactions

Vesix Special may increase the ototoxic potential of aminoglycoside antibiotics, especially in the presence of impaired renal function. Except in life-threatening situations, avoid this combination.

Vesix Special should not be used concomitantly with ethacrynic acid because of the possibility of ototoxicity. Patients receiving high doses of salicylates concomitantly with Vesix Special, as in rheumatic disease, may experience salicylate toxicity at lower doses because of competitive renal excretory sites.

There is a risk of ototoxic effects if cisplatin and Vesix Special are given concomitantly. In addition, nephrotoxicity of nephrotoxic drugs such as cisplatin may be enhanced if Vesix Special is not given in lower doses and with positive fluid balance when used to achieve forced diuresis during cisplatin treatment.

Vesix Special has a tendency to antagonize the skeletal muscle relaxing effect of tubocurarine and may potentiate the action of succinylcholine.

Lithium generally should not be given with diuretics because they reduce lithium's renal clearance and add a high risk of lithium toxicity.

Vesix Special combined with angiotensin converting enzyme inhibitors or angiotensin II receptor blockers may lead to severe hypotension and deterioration in renal function, including renal failure. An interruption or reduction in the dosage of Vesix Special, angiotensin converting enzyme inhibitors, or angiotensin receptor blockers may be necessary.

Potentiation occurs with ganglionic or peripheral adrenergic blocking drugs.

Vesix Special may decrease arterial responsiveness to norepinephrine. However, norepinephrine may still be used effectively.

Simultaneous administration of sucralfate and Vesix Special tablets may reduce the natriuretic and antihypertensive effects of Vesix Special. Patients receiving both drugs should be observed closely to determine if the desired diuretic and/or antihypertensive effect of Vesix Special is achieved. The intake of Vesix Special and sucralfate should be separated by at least two hours.

In isolated cases, intravenous administration of Vesix Special within 24 hours of taking chloral hydrate may lead to flushing, sweating attacks, restlessness, nausea, increase in blood pressure, and tachycardia. Use of Vesix Special concomitantly with chloral hydrate is therefore not recommended.

Phenytoin interferes directly with renal action of Vesix Special. There is evidence that treatment with phenytoin leads to decrease intestinal absorption of Vesix Special, and consequently to lower peak serum Vesix Special concentrations.

Methotrexate and other drugs that, like Vesix Special, undergo significant renal tubular secretion may reduce the effect of Vesix Special. Conversely, Vesix Special may decrease renal elimination of other drugs that undergo tubular secretion. High-dose treatment of both Vesix Special and these other drugs may result in elevated serum levels of these drugs and may potentiate their toxicity as well as the toxicity of Vesix Special.

Vesix Special can increase the risk of cephalosporin-induced nephrotoxicity even in the setting of minor or transient renal impairment.

Concomitant use of cyclosporine and Vesix Special is associated with increased risk of gouty arthritis secondary to Vesix Special-induced hyperurecemia and cyclosporine impairment of renal urate excretion.

High doses ( > 80 mg) of Vesix Special may inhibit the binding of thyroid hormones to carrier proteins and result in transient increase in free thyroid hormones, followed by an overall decrease in total thyroid hormone levels.

One study in six subjects demonstrated that the combination of Vesix Special and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency. There are case reports of patients who developed increased BUN, serum creatinine and serum potassium levels, and weight gain when Vesix Special was used in conjunction with NSAIDs.

Literature reports indicate that coadministration of indomethacin may reduce the natriuretic and antihypertensive effects of Vesix Special (Vesix Special) in some patients by inhibiting prostaglandin synthesis. Indomethacin may also affect plasma renin levels, aldosterone excretion, and renin profile evaluation. Patients receiving both indomethacin and Vesix Special should be observed closely to determine if the desired diuretic and/or antihypertensive effect of Vesix Special is achieved.

References

1. DailyMed. "FUROSEMIDE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
2. FDA/SPL Indexing Data. "7LXU5N7ZO5: The UNique Ingredient Identifier (UNII) is an alphanumeric substance identifier from the joint FDA/USP Substance Registration System (SRS).". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
3. MeSH. "Sodium Potassium Chloride Symporter Inhibitors". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Vesix Special are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Vesix Special. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reviews

There are no reviews yet. Be the first to write one!

Your name:  Email:  Spam protection:  < Type 14 here

Information checked by Dr. Sachin Kumar, MD Pharmacology